Freedom to Operate (FTO) Analysis

A freedom to operate (FTO) analysis — also called an FTO search, clearance search, or right-to-use opinion — is an investigation into whether making, using, selling, offering to sell, or importing a specific product or process would infringe any third party’s valid, in-force patent claims in the jurisdictions where the activity will occur. It answers one narrow question: will doing THIS infringe someone ELSE’S patent? It says nothing about whether the product or process is itself patentable, novel, or inventive — that is a separate question, answered by a different kind of search entirely.

FTO vs. patentability / prior art search — the distinction that trips people up

The single most common confusion in tech transfer and product development is treating a clean prior art search or an issued patent as proof of freedom to operate. They are not the same question, and a positive result on one says nothing about the other:

• Patentability / prior art search asks: “Can WE get a patent on OUR invention?” It searches for prior art that would defeat novelty or non-obviousness under standards like 35 U.S.C. § 102/103, and it evaluates your claims against what came before.
• Freedom to operate analysis asks: “Will making, using, or selling THIS product infringe someone ELSE’S patent?” It searches for granted, in-force patents whose claims might read on your product as actually made and sold — regardless of whether your own contribution is novel.

These can point in opposite directions at once. A classic scenario is an improvement patent: an inventor develops a genuinely novel enhancement to an existing device and is granted their own patent on that improvement — patentability is satisfied. But if making or selling the improved device still requires practicing the base, unimproved invention that a competitor already holds a valid, in-force patent on, the improver can be blocked from commercializing without a license from that competitor. Owning a patent on an invention has never, by itself, given the owner the right to make, use, or sell it — only the right to exclude others. Freedom to operate is the separate check for whether anyone else’s patent excludes you.

Why FTO is jurisdiction-specific and time-bound

Patent rights are territorial: a patent granted in one country has no legal force in another. An FTO analysis is only valid for the specific country or countries it was conducted for — clearance in the United States says nothing about freedom to operate in the European Union, Japan, or any other market, and each must be searched and opined on separately if the product will be made, used, or sold there. An FTO opinion is also a snapshot: it reflects patents that are granted and in force (or published applications that could still issue) as of the search date. It does not, and cannot, account for patent applications filed after that date, since pending applications are typically not published until roughly 18 months after their earliest priority date and remain invisible to any search conducted before publication.

When it’s done, and why timing matters

FTO analysis is typically run before committing significant resources to commercializing a technology: before scaling manufacturing, before a university spinout launches a product built on licensed or internally developed IP, before entering a new geographic market, and often as a condition investors or acquirers attach to funding or due diligence. Running it early matters because the available responses to a blocking patent — designing around the claim, negotiating a license, challenging the patent’s validity, or abandoning that product direction — are all cheaper and more flexible before a product design is locked in and capital has been spent on tooling, regulatory submissions, or market launch. Finding a blocking patent after launch narrows the options considerably and adds the risk of enhanced damages for willful infringement under 35 U.S.C. § 284 if the infringer is shown to have known of the patent and proceeded regardless.

How an FTO analysis is typically structured

1. Define the product or process precisely — every material, component, method step, and manufacturing process that will actually be practiced, not just the headline invention.
2. Identify the target jurisdictions — every country where the product will be made, used, sold, offered for sale, or imported.
3. Search for potentially relevant patents — granted, in-force patents and published pending applications in each jurisdiction whose claims could plausibly cover any element of the product, typically via USPTO, EPO Espacenet, WIPO PATENTSCOPE, or commercial patent-search platforms.
4. Build claim charts — for each candidate patent, map every element of at least one independent claim against the actual product to determine whether the claim reads on it. See CASRAI’s guide on the patent claim chart for how this element-by-element mapping is built and used as evidence.
5. Assess status and validity — confirm the candidate patent is still in force (not expired, lapsed for non-payment of maintenance fees, or invalidated), and consider whether it has real validity weaknesses worth investigating further.
6. Obtain a legal opinion — patent counsel issues a written FTO or clearance opinion summarizing the risk for each identified patent and, where relevant, documenting a good-faith basis for a non-infringement or invalidity position.

What FTO does not do

An FTO analysis reduces risk; it does not eliminate it. It cannot find unpublished pending applications, it does not predict future filings, and it is an opinion at a point in time rather than a guarantee against future litigation or a court’s own claim construction. In university technology transfer specifically, a licensing office generally does not warrant freedom to operate as part of a license agreement — FTO depends heavily on how the licensee ultimately designs and markets the product, which the institution does not control, so most university licenses disclaim any FTO warranty and leave the licensee responsible for its own analysis. See CASRAI’s guides on technology licensing due diligence and license agreement structure for how FTO responsibility is typically allocated between licensor and licensee.

Examples

Example 1. A university spinout has secured its own patent on a novel biomarker combination for a diagnostic test — patentability is confirmed. Before scaling manufacturing, its patent counsel runs an FTO search for the U.S. market and finds an unrelated competitor’s in-force patent whose claims cover the specific sample-preparation cartridge design the diagnostic device relies on. Rather than launching and risking infringement, the spinout redesigns the cartridge to avoid the blocking claim before commercial launch.

Example 2. A company preparing a U.S. product launch finds that the closest potentially blocking patent expired 14 months earlier for failure to pay a maintenance fee — confirming freedom to operate in the U.S. for that specific claim. A search of the same patent family in the European Patent Register shows a corresponding European patent still has three years of term remaining, so the same product could still infringe if sold into the EU — illustrating why FTO clearance in one jurisdiction does not carry over to another.

Counter-example. A company runs only a patentability search on its own invention, receives no novelty or obviousness rejections, and treats that as confirmation it is clear to launch. This is not an FTO analysis and does not function as one: a clean patentability result says nothing about whether a competitor holds a broader, already-issued patent — for example, a genus patent covering a wider class of compounds or designs that the company’s specific product falls within. Only a dedicated FTO search, covering third-party patents rather than the applicant’s own prior art landscape, answers that question.

Related terms

Prior art is the evidentiary basis for a patentability search, the concept FTO is most often confused with. A patent claim chart is the core analytical tool used inside an FTO analysis to map claims to a product.